News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,921 Results
Type
Article (10238)
Company Profile (32)
Press Release (147651)
Section
Business (47584)
Career Advice (225)
Deals (7047)
Drug Delivery (17)
Drug Development (14479)
Employer Resources (19)
FDA (4006)
Job Trends (3217)
News (73348)
Policy (5545)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (1)
Academia (792)
Academic (1)
Adcomms (1)
Allergies (16)
Alliances (15597)
ALS (9)
Alzheimer's disease (462)
Antibody-drug conjugate (ADC) (16)
Approvals (4007)
Artificial intelligence (109)
Autoimmune disease (2)
Automation (3)
Bankruptcy (56)
Best Places to Work (2628)
Biosimilars (14)
Biotechnology (19)
Bladder cancer (10)
Brain cancer (10)
Breast cancer (81)
Cancer (623)
Cardiovascular disease (26)
Career advice (201)
Career pathing (6)
CAR-T (20)
Cell therapy (55)
Cervical cancer (5)
Clinical research (10741)
Collaboration (237)
Compensation (19)
Complete response letters (2)
COVID-19 (785)
CRISPR (3)
C-suite (59)
Cystic fibrosis (15)
Data (383)
Decentralized trials (1)
Denatured (1)
Depression (7)
Diabetes (37)
Diagnostics (5942)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (33)
Drug pricing (5)
Drug shortages (5)
Duchenne muscular dystrophy (11)
Earnings (14229)
Editorial (4)
Employer branding (6)
Employer resources (17)
Events (19943)
Executive appointments (154)
FDA (4227)
Featured Employer (9)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (172)
Gene editing (12)
Generative AI (11)
Gene therapy (42)
GLP-1 (125)
Government (899)
Guidances (6)
Healthcare (4102)
Huntington's disease (5)
IgA nephropathy (2)
Immunology and inflammation (22)
Indications (5)
Infectious disease (814)
Inflammatory bowel disease (27)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (9)
Interviews (24)
IPO (2515)
IRA (3)
Job creations (684)
Job search strategy (187)
Kidney cancer (5)
Labor market (1)
Layoffs (70)
Leadership (3)
Legal (806)
Liver cancer (27)
Lung cancer (87)
Lymphoma (48)
Management (4)
Manufacturing (57)
MASH (7)
Medical device (2681)
Medtech (2681)
Mergers & acquisitions (4610)
Metabolic disorders (100)
Multiple sclerosis (27)
NASH (4)
Neurodegenerative disease (24)
Neuropsychiatric disorders (3)
Neuroscience (560)
NextGen: Class of 2025 (1097)
Non-profit (907)
Northern California (498)
Now hiring (7)
Obesity (55)
Opinion (44)
Ovarian cancer (19)
Pain (7)
Pancreatic cancer (17)
Parkinson's disease (23)
Partnered (5)
Patents (32)
Patient recruitment (14)
Peanut (9)
People (15423)
Pharmaceutical (3)
Phase I (3740)
Phase II (4650)
Phase III (3605)
Pipeline (181)
Podcasts (12)
Policy (8)
Postmarket research (456)
Preclinical (2120)
Press Release (25)
Prostate cancer (38)
Psychedelics (3)
Radiopharmaceuticals (141)
Rare diseases (48)
Real estate (1233)
Recruiting (9)
Regulatory (4251)
Reports (12)
Research institute (929)
Resumes & cover letters (29)
RNA editing (1)
RSV (1)
Schizophrenia (7)
Series A (28)
Series B (16)
Service/supplier (2)
Sickle cell disease (2)
Southern California (370)
Special edition (3)
Sponsored (6)
Startups (1029)
Stomach cancer (4)
Supply chain (6)
The Weekly (11)
United States (4108)
Vaccines (86)
Venture capitalists (8)
Webinars (3)
Weight loss (35)
Women's health (6)
Worklife (1)
Date
Today (24)
Last 7 days (134)
Last 30 days (699)
Last 365 days (7918)
2025 (1391)
2024 (7983)
2023 (9537)
2022 (14543)
2021 (14115)
2020 (13030)
2019 (9269)
2018 (7165)
2017 (7911)
2016 (7720)
2015 (9068)
2014 (6632)
2013 (5823)
2012 (6233)
2011 (6651)
2010 (5968)
Location
Africa (194)
Alabama (7)
Alaska (2)
Arizona (58)
Arkansas (2)
Asia (8271)
Australia (1647)
California (1066)
Canada (332)
China (87)
Colorado (56)
Connecticut (70)
Delaware (15)
Europe (23432)
Florida (114)
Georgia (39)
Idaho (6)
Illinois (120)
India (8)
Indiana (42)
Iowa (3)
Japan (28)
Kansas (12)
Kentucky (5)
Louisiana (1)
Maine (22)
Maryland (122)
Massachusetts (663)
Michigan (75)
Minnesota (94)
Missouri (27)
Montana (4)
Nebraska (8)
Nevada (3)
New Hampshire (19)
New Jersey (232)
New Mexico (19)
New York (398)
North Carolina (210)
North Dakota (6)
Northern California (498)
Ohio (33)
Oklahoma (3)
Oregon (8)
Pennsylvania (137)
Rhode Island (4)
South America (217)
South Carolina (2)
Southern California (370)
Tennessee (25)
Texas (198)
Utah (90)
Virginia (41)
Washington D.C. (10)
Washington State (154)
Wisconsin (28)
157,921 Results for "roche molecular diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children with one or more food allergies.
March 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
January 22, 2025
·
5 min read
Press Releases
Molecular Diagnostics Market Size Forecasted to Hit USD 63.86 Bn By 2034
February 19, 2025
·
1 min read
Press Releases
North America Molecular Diagnostics Market Size to Hit USD 8.91 Billion by 2034
February 26, 2025
·
1 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Point-of-Care Molecular Diagnostics Market Size to Exceed USD 12.61 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities
December 13, 2024
·
3 min read
Earnings
Roche to Stay ‘Disciplined’ With Deals in 2025
For 2025, Roche will continue a careful approach to high-priced deals, putting science at the center of its business development decisions, executives said Thursday.
January 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Oncocytoma Market Expected to Exhibit a CAGR of 5.24% during 2025-2035, Impelled by Emerging Role of Molecular Diagnostics
February 19, 2025
·
9 min read
Deals
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech.
May 2, 2024
·
5 min read
1 of 15,793
Next
